People taking the newest antipsychotic drugs are twice as likely to suffer heart attacks and death as non-users according to a study published in the New England Journal of Medicine. In other words they're no more safe than the older drugs they're replacing.
Sales of atypical antipsychotic drugs were up 12% in 2007 to $13.23 billion.
And the pharmaceutical industry calls this progress.
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment